FIELD: biotechnology.
SUBSTANCE: invention relates to polypeptides for treatment or prevention of allergies to pollen Ph1P1, birch Betv1 pollen and Derp2 home dust mite allergens, which can be used in medicine. The recombinantly obtained polypeptides of SEQ ID NO: 14-19 and 149-152 are used in vaccine compositions intended to treat or prevent response to corresponding allergens.
EFFECT: decreased number of side effects when vaccinated with Ph1P1, Betv1 and Derp2 allergens.
33 cl, 20 dwg, 7 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
MODIFICATION OF GROUP 6 POACEAE (BLUEGRASS) ALLERGENS WITH LOW ALLERGENIC CAPACITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2607373C2 |
DNA SEQUENCE AND PRODUCTION OF GRASS POLLEN ALLERGEN Phi p4 USING RECONBINANT METHODS | 2003 |
|
RU2327739C2 |
VARIANTS OF GROUP 5 ALLERGENS OF CEREALS WITH REDUCED ALLERGENICITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2658767C1 |
VERSIONS OF GROUP OF 5 ALLERGENS OF TRUE GRASSES WITH REDUCED ALLERGENICITY RESULTING FROM MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2575606C2 |
RECOMBINANT POLYPEPTIDE BASED ON BIRCH POLLEN ALLERGEN AND APPLE ALLERGEN AS AN ALLERGY VACCINE | 2020 |
|
RU2761431C1 |
HOUSE DUST MITE PROTEIN | 2007 |
|
RU2570563C2 |
VARIANTS OF PRINCIPAL ALLERGEN Phl p 1 FROM TIMOTHY GRASS (PHLEUM PRATENSE) | 2003 |
|
RU2323942C2 |
DNA SEQUENCE AND RECOMBINANT PRODUCTION OF MAIN ALLERGENS OF GROUP 4 FROM POACEAE | 2004 |
|
RU2373283C2 |
TREATMENT AND PREVENTION OF ALLERGY TO HOUSE DUST MITES | 2019 |
|
RU2815386C2 |
VERSION OF GROUP I Poaceae ALLERGEN CHARACTERISED BY LOWER ALLERGENICITY AND MAINTAINED T-CELL RESPONSIVENESS (VERSIONS), CODING DNA MOLECULE AND APPLICATION THEREOF | 2005 |
|
RU2409589C2 |
Authors
Dates
2017-09-11—Published
2012-06-11—Filed